Literature DB >> 20497990

Does information on systolic and diastolic function improve prediction of a cardiovascular event by left ventricular hypertrophy in arterial hypertension?

Giovanni de Simone1, Raffaele Izzo, Marcello Chinali, Marina De Marco, Giuseppina Casalnuovo, Francesco Rozza, Daniela Girfoglio, Gianni Luigi Iovino, Bruno Trimarco, Nicola De Luca.   

Abstract

Left ventricular (LV) mass (LVM) is the most important information requested in hypertensive patients referred for echocardiography. However, LV function also predicts cardiovascular (CV) risk independent of LVM. There is no evidence that addition of LV function significantly improves model prediction of CV risk compared with LVM alone. Thus, composite fatal and nonfatal CV or cerebrovascular events were evaluated in 5380 hypertensive outpatients (2336 women, 298 diabetics, and 1315 obese subjects) without prevalent CV disease (follow-up: 3.5+/-2.8 years). We compared 5 risk models using Cox regression and adjusting for age and sex: (1) LV mass normalized for height in meters(2.7) (LVMi); (2) LVMi, concentric LV geometry, by relative wall thickness (>0.43), ejection fraction, and transmitral diastolic pattern (by thirtiles of mitral deceleration index); (3) LVMi, LV geometry, midwall shortening, and mitral deceleration index thirtiles; (4) as No. 2 with the addition of left atrial dilatation (>23 mm); and (5) as No. 3 with the addition of left atrial dilatation. Individual hazard functions were compared using receiving operating characteristic curves and z statistics. Areas under the curves increased from 0.60 in the model with the sole LVMi to 0.62 in the others (all P values for differences were not significant). The additional information on systolic and diastolic function decreased the contribution (Wald statistics) of LVMi in the Cox model without improving the model ability to predict CV risk. We conclude that risk models with inclusion of information on LV geometry and systolic and diastolic function, in addition to LVMi, do not improve the prediction of CV events but rather redistribute the impact of individual predictors within the risk variance.

Entities:  

Mesh:

Year:  2010        PMID: 20497990     DOI: 10.1161/HYPERTENSIONAHA.110.150128

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  22 in total

1.  Echocardiography in hypertension: a call for standardization from the Working Group on Heart and Hypertension of the Italian Society of Hypertension.

Authors:  Cesare Cuspidi; Maria Lorenza Muiesan; Nicola De Luca; Massimo Salvetti; Enrico Agabiti-Rosei; Giuseppe Schillaci
Journal:  High Blood Press Cardiovasc Prev       Date:  2013-11-08

2.  Relative fat-free mass deficiency and left ventricular adaptation to obesity: the Strong Heart Study.

Authors:  Giovanni de Simone; Fabrizio Pasanisi; Aldo L Ferrara; Mary J Roman; Elisa T Lee; Franco Contaldo; Barbara V Howard; Richard B Devereux
Journal:  Int J Cardiol       Date:  2012-10-09       Impact factor: 4.164

3.  Antihypertensive response to combination of olmesartan and amlodipine does not depend on method and time of drug administration.

Authors:  Francesco Rozza; Valentina Trimarco; Raffaele Izzo; Mario Santoro; Maria Virginia Manzi; Marina Marino; Gianfranco Di Renzo; Bruno Trimarco
Journal:  High Blood Press Cardiovasc Prev       Date:  2013-05-09

Review 4.  How to identify hypertensive patients at high cardiovascular risk? The role of echocardiography.

Authors:  Cesare Cuspidi; Marijana Tadic; Carla Sala; Guido Grassi
Journal:  High Blood Press Cardiovasc Prev       Date:  2015-03-07

5.  Left atrial volume index predictive of mortality independent of left ventricular geometry in a large clinical cohort with preserved ejection fraction.

Authors:  Dharmendrakumar A Patel; Carl J Lavie; Richard V Milani; Hector O Ventura
Journal:  Mayo Clin Proc       Date:  2011-08       Impact factor: 7.616

6.  Identification of phenotypes at risk of transition from diastolic hypertension to isolated systolic hypertension.

Authors:  R Esposito; R Izzo; M Galderisi; M De Marco; E Stabile; G Esposito; V Trimarco; F Rozza; N De Luca; G de Simone
Journal:  J Hum Hypertens       Date:  2015-09-10       Impact factor: 3.012

Review 7.  Left heart morphology and function in primary aldosteronism.

Authors:  Alberto Milan; Corrado Magnino; Ambra Fabbri; Michela Chiarlo; Giulia Bruno; Isabel Losano; Franco Veglio
Journal:  High Blood Press Cardiovasc Prev       Date:  2012-03-01

Review 8.  Echocardiography in Arterial Hypertension.

Authors:  Giovanni de Simone; Costantino Mancusi; Roberta Esposito; Nicola De Luca; Maurizio Galderisi
Journal:  High Blood Press Cardiovasc Prev       Date:  2018-05-02

9.  Morphologic and Functional Heart Abnormalities Associated to High Modified Tei Index in Hypertensive Patients.

Authors:  G Tissera; Daniel Piskorz; L Citta; N Citta; P Citta; L Keller; L Bongarzoni; L Mata; A Tommasi
Journal:  High Blood Press Cardiovasc Prev       Date:  2016-09-13

10.  Associations of Left Ventricular Hypertrophy and Geometry with Adverse Outcomes in Patients with CKD and Hypertension.

Authors:  Ernesto Paoletti; Luca De Nicola; Francis B Gabbai; Paolo Chiodini; Maura Ravera; Laura Pieracci; Sonia Marre; Paolo Cassottana; Sergio Lucà; Simone Vettoretti; Silvio Borrelli; Giuseppe Conte; Roberto Minutolo
Journal:  Clin J Am Soc Nephrol       Date:  2015-12-14       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.